Zai Lab (ZLAB) Share-based Compensation (2020 - 2026)
Zai Lab's (ZLAB) quarterly Share-based Compensation came in at $13.5 million in Q1 2026, down 14.41% year-on-year from $15.8 million in Q1 2025, and down 14.95% quarter-over-quarter from $15.9 million in Q4 2025.
Zai Lab (ZLAB) Share-based Compensation (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Share-based Compensation across 7 years of filings, most recently posting $13.5 million for Q1 2026.
- Share-based Compensation for Q1 2026 came in at $13.5 million, down 14.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $63.3 million (down 7.52% YoY), and the FY2025 annual result was $65.6 million, down 7.15% from the prior year.
- Share-based Compensation came in at $13.5 million for Q1 2026 at Zai Lab, down from $15.9 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $22.0 million in Q3 2023 to a low of $12.4 million in Q1 2022.
- The 5-year median for Share-based Compensation is $16.9 million (2025), against an average of $17.1 million.
- Across the five-year window, Share-based Compensation surged 81.02% in 2022 and declined 23.63% in 2024, its largest moves.
- Zai Lab's Share-based Compensation stood at $15.6 million in 2022, then soared by 31.56% to $20.5 million in 2023, then retreated by 15.79% to $17.2 million in 2024, then decreased by 7.75% to $15.9 million in 2025, then fell by 14.95% to $13.5 million in 2026.
- The last three Share-based Compensation figures came in at $13.5 million (Q1 2026), $15.9 million (Q4 2025), and $16.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 13.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.52 Mn |
| Mar 31, 2026 | 13.52 Mn |
| Dec 31, 2025 | 15.90 Mn |
| Dec 31, 2025 | 15.90 Mn |
| Sep 30, 2025 | 16.92 Mn |
| Sep 30, 2025 | 16.92 Mn |
| Jun 30, 2025 | 16.97 Mn |
| Jun 30, 2025 | 16.97 Mn |
| Mar 31, 2025 | 15.80 Mn |
| Mar 31, 2025 | 15.80 Mn |
| Dec 31, 2024 | 17.24 Mn |
| Dec 31, 2024 | 17.24 Mn |
| Sep 30, 2024 | 16.80 Mn |
| Sep 30, 2024 | 16.80 Mn |
| Jun 30, 2024 | 18.64 Mn |
| Jun 30, 2024 | 18.64 Mn |
| Mar 31, 2024 | 17.98 Mn |
| Mar 31, 2024 | 17.98 Mn |
| Dec 31, 2023 | 20.47 Mn |
| Dec 31, 2023 | 20.47 Mn |